▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3333 by analyst upside · 2026-11-14
ALGN
Align Technology, Inc.
Healthcare · Market Cap $12B · P/E 24.4x
ANALYST PRICE TARGET
+10.4%
implied upside to consensus target
Current Price $168.32
Consensus Target $185.79
Bull Target $210.0
Bear Target $160.0
Analysts Covering 14
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
4
Hold
7
Sell
1
52-Week Low $130.23
52-Week High $200.44
YTD Return +7.9%
FUNDAMENTALS
Market Cap $12B
P/E Ratio (TTM) 24.4x
Forward P/E 13.7x
EPS (TTM) $6.91
PEG Ratio 0.77
Dividend Yield N/A
Revenue (TTM) $4.2B
Profit Margin 11.8%
52-WEEK RANGE
52-Week Low $130.23
52-Week High $200.44
Current Price $168.32
Bear Target $160.0
Bull Target $210.0
● Now $168.32 ● Target $185.79
TRADING DATA
Avg Volume 1000K
YTD Return +7.9%
Analyst Count 14
Consensus Buy
Upside to Target +10.4%
Last Updated 2026-11-14

ANALYST SUMMARY

Align Technology, Inc. (ALGN) is currently trading at $168.32 with a Wall Street consensus price target of $185.79, implying potential upside of 10.4% over the next 12 months. 14 analysts currently cover ALGN, with a consensus rating of Buy - 43% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $210.0, while the most cautious has a target of $160.0.

ALGN operates in the Healthcare sector with a market capitalisation of $12B. The stock is up 7.9% year-to-date and is currently trading near the upper end of its 52-week range of $130.23 – $200.44.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

COO +5.0%
The Cooper Companies, Inc.
$12B · P/E 21.4x · Hold
FMS -0.2%
Fresenius Medical Care AG
$11B · P/E 12.7x · Hold
SNN +6.1%
Smith & Nephew plc
$13B · P/E 21.1x · Hold
PODD +17.1%
Insulet Corporation
$11B · P/E 24.9x · Buy
EHC +10.7%
Encompass Health Corporation
$14B · P/E 22.6x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ALGN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-10-29 Building track record
Mizuho - Reiterated
Outperform → Outperform 2026-10-22 Building track record
Piper Sandler - Reiterated
Overweight → Overweight 2026-10-21 14% win rate (7 calls)
Baird ↓ Downgrade
Outperform → Neutral 2026-10-15 Building track record
Leerink Partners - Reiterated
Outperform → Outperform 2026-10-14 29% win rate (7 calls)
Stifel - Reiterated
Buy → Buy 2026-10-09 Building track record
Evercore ISI Group ↓ Downgrade
Outperform → In-Line 2026-10-05 Building track record
UBS - Reiterated
Neutral → Neutral 2026-07-23 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
52
out of 100
Coverage depth
21/30
Consensus clarity
24/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →